RhoB, not RhoA, represses the transcription of the transforming growth factor beta type II receptor by a mechanism involving activator protein 1 - PubMed (original) (raw)

. 2002 Mar 8;277(10):8500-7.

doi: 10.1074/jbc.M104367200. Epub 2001 Dec 11.

Affiliations

• PMID: 11741970
• DOI: 10.1074/jbc.M104367200

Free article

RhoB, not RhoA, represses the transcription of the transforming growth factor beta type II receptor by a mechanism involving activator protein 1

Jalila Adnane et al. J Biol Chem. 2002.

Free article

Abstract

The transforming growth factor-beta (TGF-beta) type I (T beta R-I) and type II (T beta R-II) receptors are responsible for transducing TGF-beta signals. We have previously shown that inhibition of farnesyltransferase activity results in an increase in T beta R-II expression, leading to enhanced TGF-beta binding, signaling, and inhibition of tumor cell growth, suggesting that a farnesylated protein(s) exerts a repressive effect on T beta R-II expression. Likely candidates are farnesylated proteins such as Ras and RhoB, which are both farnesylated and involved in cell growth control. Neither a dominant negative Ha-Ras, constitutively activated Ha-Ras, or a pharmacological inhibitor of MEK1 affected T beta R-II transcription. However, ectopic expression of RhoB, but not the closely related family member RhoA, resulted in a 5-fold decrease of T beta R-II promoter activity. Furthermore, ectopic expression of RhoB, but not RhoA, resulted in a significant decrease of T beta R-II protein expression and resistance of tumor cells to TGF-beta-mediated cell growth inhibition. Deletion analysis of the T beta R-II promoter identified a RhoB-responsive region, and mutational analysis of this region revealed that a site for the transcription factor activator protein 1 (AP1) is critical for RhoB-mediated repression of T beta R-II transcription. Electrophoretic mobility shift assays clearly showed that the binding of AP1 to its DNA-binding site is strongly inhibited by RhoB. Consequently, transcription assays using an AP1 reporter showed that AP1-mediated transcription is down-regulated by RhoB. Altogether, these results identify a mechanism by which RhoB antagonizes TGF-beta action through transcriptional down-regulation of AP1 in T beta R-II promoter.

PubMed Disclaimer

Similar articles

• Palmitoylated cysteine 192 is required for RhoB tumor-suppressive and apoptotic activities.
  Wang DA, Sebti SM. Wang DA, et al. J Biol Chem. 2005 May 13;280(19):19243-9. doi: 10.1074/jbc.M411472200. Epub 2005 Feb 15. J Biol Chem. 2005. PMID: 15713677
• Rap1 reverses transcriptional repression of TGF-beta type II receptor by a mechanism involving AP-1 in the human pancreatic cancer cell line, UK Pan-1.
  Fralix KD, Zhao S, Venkatasubbarao K, Freeman JW. Fralix KD, et al. J Cell Physiol. 2003 Jan;194(1):88-99. doi: 10.1002/jcp.10192. J Cell Physiol. 2003. PMID: 12447993
• Transcriptional regulation of the small GTPase RhoB gene by TGF{beta}-induced signaling pathways.
  Vasilaki E, Papadimitriou E, Tajadura V, Ridley AJ, Stournaras C, Kardassis D. Vasilaki E, et al. FASEB J. 2010 Mar;24(3):891-905. doi: 10.1096/fj.09-134742. Epub 2009 Nov 4. FASEB J. 2010. PMID: 19890017
• Transcriptional and post-transcriptional regulation of the genes encoding the small GTPases RhoA, RhoB, and RhoC: implications for the pathogenesis of human diseases.
  Nomikou E, Livitsanou M, Stournaras C, Kardassis D. Nomikou E, et al. Cell Mol Life Sci. 2018 Jun;75(12):2111-2124. doi: 10.1007/s00018-018-2787-y. Epub 2018 Mar 2. Cell Mol Life Sci. 2018. PMID: 29500478 Free PMC article. Review.
• The RhoB small GTPase in physiology and disease.
  Vega FM, Ridley AJ. Vega FM, et al. Small GTPases. 2018 Sep 3;9(5):384-393. doi: 10.1080/21541248.2016.1253528. Epub 2016 Nov 22. Small GTPases. 2018. PMID: 27875099 Free PMC article. Review.

Cited by

• E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines.
  Lombaerts M, van Wezel T, Philippo K, Dierssen JW, Zimmerman RM, Oosting J, van Eijk R, Eilers PH, van de Water B, Cornelisse CJ, Cleton-Jansen AM. Lombaerts M, et al. Br J Cancer. 2006 Mar 13;94(5):661-71. doi: 10.1038/sj.bjc.6602996. Br J Cancer. 2006. PMID: 16495925 Free PMC article.
• Developmental expression of three small GTPases in the mouse eye.
  Mitchell DC, Bryan BA, Liu JP, Liu WB, Zhang L, Qu J, Zhou X, Liu M, Li DW. Mitchell DC, et al. Mol Vis. 2007 Jul 13;13:1144-53. Mol Vis. 2007. PMID: 17653061 Free PMC article.
• TGFbeta3 signaling activates transcription of the LEF1 gene to induce epithelial mesenchymal transformation during mouse palate development.
  Nawshad A, Hay ED. Nawshad A, et al. J Cell Biol. 2003 Dec 22;163(6):1291-301. doi: 10.1083/jcb.200306024. J Cell Biol. 2003. PMID: 14691138 Free PMC article.
• Androgen control of cell proliferation and cytoskeletal reorganization in human fibrosarcoma cells: role of RhoB signaling.
  Chauhan S, Kunz S, Davis K, Roberts J, Martin G, Demetriou MC, Sroka TC, Cress AE, Miesfeld RL. Chauhan S, et al. J Biol Chem. 2004 Jan 9;279(2):937-44. doi: 10.1074/jbc.M311325200. Epub 2003 Oct 23. J Biol Chem. 2004. PMID: 14576147 Free PMC article.
• Transforming growth factor beta1 receptor II is downregulated by E1A in adenovirus-infected cells.
  Tarakanova VL, Wold WS. Tarakanova VL, et al. J Virol. 2003 Sep;77(17):9324-36. doi: 10.1128/jvi.77.17.9324-9336.2003. J Virol. 2003. PMID: 12915548 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • BioCyc

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal